These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3754242)

  • 21. Editorial: Delay time of gelation: a possible determinant of clinical severity in sickle cell disease.
    Eaton WA; Hofrichter J; Ross PD
    Blood; 1976 Apr; 47(4):621-7. PubMed ID: 1260125
    [No Abstract]   [Full Text] [Related]  

  • 22. Facilitation of Hb S polymerization by the substitution of Glu for Gln at beta 121.
    Adachi K; Kim J; Ballas S; Surrey S; Asakura T
    J Biol Chem; 1988 Apr; 263(12):5607-10. PubMed ID: 2895770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing haemoglobin oxygen affinity to prevent sickling: abnormal haemoglobin variants as models.
    Franklin IM; Huehns ER; Rosemeyer MA
    Br J Haematol; 1986 Oct; 64(2):319-29. PubMed ID: 3778826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic model for observed distributions of proportions of haemoglobin in sickle-cell trait.
    Brittenham G
    Nature; 1977 Aug; 268(5621):635-6. PubMed ID: 895858
    [No Abstract]   [Full Text] [Related]  

  • 25. Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (first of three parts).
    Dean J; Schechter AN
    N Engl J Med; 1978 Oct; 299(14):752-63. PubMed ID: 357967
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of alpha thalassaemia in sickle cell trait patients by Hb-Bart's screening & quantitation of Hb-A & Hb-S.
    Misra RC
    Indian J Med Res; 1989 Dec; 90():459-62. PubMed ID: 2628314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical modifications that inhibit gelation of sickle hemoglobin.
    Benesch R; Benesch RE; Yung S
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1504-5. PubMed ID: 4524653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hb S Mobile: a new genetic combination.
    Schneider RG; Zusman J; Smith WB; King TD; Brimhall B; Shih T; Jones RT
    Hemoglobin; 1983; 7(6):521-31. PubMed ID: 6668186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidation properties of two hemoglobin variants with their mutation localized in the heme pocket: Hb Castilla beta 32 (B14) Leu replaced by Arg and Hb Toulouse beta 66 (E10) Lys replaced by Glu, and abnormal functional properties of Hb Castilla.
    Thillet J; Garel MC; Bierme R; Rosa J
    Biochim Biophys Acta; 1980 Jul; 624(1):293-303. PubMed ID: 7407240
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemoglobin Warwickshire (beta 5 [A2] Pro----Arg). A possible 'fine tuning' of 2,3-DPG affinity by beta 5 Pro.
    Wilson CI; Cave RJ; Lehmann H; Close M; Imai K
    FEBS Lett; 1984 Oct; 176(2):331-3. PubMed ID: 6548451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Abnormal hemoglobins identified in Martinique].
    Monplaisir N; Galacteros F; Arous N; Rhoda MD; Delanoe-Garin J; Ouka-Montjean M; de Linval JC; Rosa J
    Nouv Rev Fr Hematol (1978); 1985; 27(1):11-4. PubMed ID: 3991355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Semiological profile of gout in patients with AA, AS and AC hemoglobins].
    Oniankitan O; Fianyo E; Houzou P; Tagbor KC; Mijiyawa M
    Tunis Med; 2010 Jan; 88(1):30-2. PubMed ID: 20415210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA diagnosis of Hb S and Hb Caribbean (alpha 2 beta 2 91 Leu-->Arg) in a Jamaican family.
    Waye JS; Patterson M; Eng B; Chui DH; Sher GD; Olivieri NF
    Am J Hematol; 1994 Sep; 47(1):33-5. PubMed ID: 8042613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyamines and globin binding in sickle cell disease.
    Natta CL; Motyczka AA; Kremzner LT
    Am J Pediatr Hematol Oncol; 1982; 4(1):73-6. PubMed ID: 7091579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First case of Hb Fontainebleau with sickle haemoglobin and other non-deletional α gene variants identified in neonates during newborn screening for sickle cell disorders.
    Upadhye DS; Jain D; Nair SB; Nadkarni AH; Ghosh K; Colah RB
    J Clin Pathol; 2012 Jul; 65(7):654-9. PubMed ID: 22461654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human hemoglobins designed for gene therapy of sickle cell disease.
    McCune SL; Reilly MP; Chomo MJ; Asakura T; Townes TM
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9852-6. PubMed ID: 7937904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subunit assembly of hemoglobins A and S.
    McDonald MJ; Shaeffer JR; Turci SM; Bunn HF
    Prog Clin Biol Res; 1981; 55():27-39. PubMed ID: 7291192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sickle hemoglobin polymerization in solution and in cells.
    Noguchi CT; Schechter AN
    Annu Rev Biophys Biophys Chem; 1985; 14():239-63. PubMed ID: 3890882
    [No Abstract]   [Full Text] [Related]  

  • 39. Solidity of sickle hemoglobin gels: relevance to pathophysiology of sickling disorders.
    Danish EH; Harris JW; Oh K
    Cleve Clin J Med; 1989; 56(8):793-800. PubMed ID: 2605778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin E2 effects on oxygen affinity by sickle erythrocytes.
    Rabinowitz I; Wolf PL; Shikuma N; Berman S
    Prostaglandins; 1974 Aug; 7(4):309-17. PubMed ID: 4415346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.